Investigation Launched into Class Action Involving Ozempic Weight Loss Drug

Did You Take An Injectable Weight Loss Drug Such As Ozempic?

If you have been taking Ozempic or any other weight loss drug and have experienced gastric problems like gastroparesis, stomach paralysis, intestinal obstruction or blockage, persistent vomiting, nausea, or diarrhea, it is important to report these issues to a doctor and seek medical care. You may be eligible for substantial compensation.

Recent investigations have revealed that patients who have taken weight loss drugs such as Ozempic®, Wegovy®, Mounjaro™, Rybelsus®, Trulicity®, and Saxenda® have reported painful side effects that are symptomatic of gastroparesis, also known as stomach paralysis.

According to a study conducted by the Departments of Ophthalmology and Visual Sciences and Medicine, as well as The Eye Care Center at the University of British, patients who used medications inhibiting GLP-1, such as Ozempic and Wegovy, had a higher risk of stomach paralysis and other issues like pancreatitis. The study utilized a methodology that involved randomly sampling data from 16 million patients between 2006 and 2020, obtained from the paid PharMetrics Plus database [1].

If you or someone you know has experienced adverse side effects, it is crucial to seek immediate medical attention. If you believe that your symptoms are directly associated with Ozempic® or similar medications, you may be eligible for compensation for your suffering. You can access the provided links to fill out a claim form if you believe you meet the criteria as a user of these Injectable Weight Loss Drugs.

What Are the Different Weight Loss Medications in the Investigation?

• Ozempic®: Ozempic® is a medication used to manage Type 2 diabetes. It contains semaglutide, which mimics the effects of GLP-1, a hormone that regulates blood sugar levels and appetite. By increasing insulin production and reducing glucose release from the liver, Ozempic® helps control blood sugar and promote weight loss in diabetic patients.

• Wegovy®: Wegovy® is another medication that contains semaglutide, but in a higher dose. It was approved by the FDA in 2021 as a weight loss medication, making it the first new weight loss medication to receive approval in several years.

• Saxenda®: Saxenda® is a GLP-1 medication that contains liraglutide. Originally approved for the management of type 2 diabetes under the brand name Victoza, Saxenda® gained approval as a weight loss medication in 2017. It is prescribed for individuals with a BMI of 30 or higher, or for those with a BMI of 27 and higher who also have a metabolic health condition. Saxenda® is not used to treat type 2 diabetes.

• Rybelsus®: Rybelsus® is an oral medication used to improve blood sugar control in adults with type 2 diabetes. It works by mimicking the effects of GLP-1, stimulating insulin secretion and reducing glucagon secretion from the liver.

• Mounjaro™: Mounjaro™, also known as tirzepatide, is an injection used to improve blood sugar levels in adults with type 2 diabetes. It helps the body regulate blood sugar levels and may decrease food intake.

• Trulicity®: Trulicity® (generic name: dulaglutide) is a medication that lowers A1C levels in individuals with type 2 diabetes. It works by limiting the amount of sugar entering the bloodstream, slowing down the digestion of food, and promoting insulin release from the pancreas after meals.

How Do I Qualify for Compensation?

The increasing popularity of weight loss drugs like Ozempic® has raised concerns about a potential connection to gastroparesis, a condition characterized by stomach paralysis. This disorder slows down the emptying of the stomach into the small intestine, causing unpleasant symptoms such as nausea, vomiting, bloating, and a feeling of fullness. In severe cases, malnutrition and other complications may arise, with no known cure available.

Many individuals affected by these medications are now seeking justice from the manufacturers, who allegedly failed to adequately warn patients about the associated risks. These companies have a responsibility to prioritize consumer safety and provide proper warnings about the potential dangers of their treatments. Victims who have suffered due to these medications are entitled to pursue compensation for medical expenses, pain and suffering, and lost wages resulting from time off work during recovery. If you or a loved one has been adversely affected by weight loss and diabetes medications like Ozempic®, you may be eligible for compensation.

Addition sources:

https://jamanetwork.com/journals/jama/fullarticle/2810542

CBC Canada: https://www.cbc.ca/news/health/ozempic-wegovy-glp-1-1.6988122

Leave a Reply

Your email address will not be published. Required fields are marked *